Arvinas to Present at the Bank of America Securities 2023

NEW HAVEN, Conn., May 03, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...

Related Keywords

United States ,America ,Sean Cassidy ,Las Vegas ,Kirsten Owens ,Jeff Boyle ,Arvinas Inc ,Nasdaq ,Business Development ,Chief Financial Officer ,Randy Teel ,Senior Vice President ,America Securities ,Discovery Engine ,Nasdaq Arvn ,Rvinas Inc ,Prostate Cancer ,Protac ,Protein Degradation ,Argetedproteindegradation ,Breast Cancer ,Immuno Oncology ,Ncology ,